Stock listing
Nervgen Pharma Corp.
Selected listing: NGEN · NASDAQ · USD · US
Nervgen Pharma Corp. (NASDAQ:NGEN), Health Technology. Latest release Sep 25, 2026: NervGen to Restate Previously Filed Financial Statements Recognizing…
- Ticker
- NASDAQ:NGEN
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Nervgen Pharma Corp.
Nervgen Pharma Corp. is a public company listed under the ticker NGEN, operating in the American market. The company focuses on developing innovative therapies for nerve damage and neurodegenerative diseases.
Latest news from Nervgen Pharma Corp.
NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments
September 25, 2026
NervGen to Host Inaugural R&D Day on September 30, 2026
September 9, 2026
NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 13, 2026
NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study
May 26, 2026
NervGen Announces Proposed Public Offering of Securities
May 21, 2026
Research Nervgen Pharma Corp.
Nervgen Pharma Corp. company profile
View the public company page for Nervgen Pharma Corp. on 6ix.
Nervgen Pharma Corp. news
Read company news and market updates connected to Nervgen Pharma Corp..
Nervgen Pharma Corp. investor events
Find investor webinars, events, and replay context for Nervgen Pharma Corp..
Alternate listings
9UA:GETTEX
DE · EUR
Alternate listing for Nervgen Pharma Corp.; the primary context on this page is NGEN:NASDAQ.
NGEN:BOATS
US · USD
Alternate listing for Nervgen Pharma Corp.; the primary context on this page is NGEN:NASDAQ.
9UA:TRADEGATE
DE · EUR
Alternate listing for Nervgen Pharma Corp.; the primary context on this page is NGEN:NASDAQ.
A2QP3D:LS
DE · EUR
Alternate listing for Nervgen Pharma Corp.; the primary context on this page is NGEN:NASDAQ.
A2QP3D:LSX
DE · EUR
Alternate listing for Nervgen Pharma Corp.; the primary context on this page is NGEN:NASDAQ.
9UA:FWB
DE · EUR
Alternate listing for Nervgen Pharma Corp.; the primary context on this page is NGEN:NASDAQ.
9UA:DUS
DE · EUR
Alternate listing for Nervgen Pharma Corp.; the primary context on this page is NGEN:NASDAQ.
9UA:HAM
DE · EUR
Alternate listing for Nervgen Pharma Corp.; the primary context on this page is NGEN:NASDAQ.
9UA:MUN
DE · EUR
Alternate listing for Nervgen Pharma Corp.; the primary context on this page is NGEN:NASDAQ.
9UA:SWB
DE · EUR
Alternate listing for Nervgen Pharma Corp.; the primary context on this page is NGEN:NASDAQ.